Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Biochemical, Serological and Immunological Tests for Diagnosis of Coronavirus Disease 2019 (COVID-19) Patients: A Comprehensive Systematic Review and Meta-analysis

Author(s): Milad Azami, Amirreza Jamshidbeigi, Hadi Esmaeili Gouvarchin Ghaleh and Reza Ranjbar*

Volume 23, Issue 7, 2023

Published on: 19 June, 2023

Article ID: e280223214172 Pages: 24

DOI: 10.2174/1871526523666230228144910

Price: $65

Abstract

Background: Recent studies have suggested the role of primary laboratory tests in addition to clinical symptoms for patients suspected to have coronavirus disease 2019 (COVID-19), which play a significant role in the diagnosis of COVID-19. However, the results of these studies are contradictory. The present study was conducted to evaluate biochemical, serological, and immunological tests for the diagnosis of COVID-19 patients.

Methods: This study was presented in accordance with the PRISMA protocol. This protocol is registered with the code CRD42019145410 in PROSPERO. We conducted a comprehensive literature search in databases, including Web of Science, PubMed/Medline, CINAHL Scopus, Cochrane Library, EMBASE, Science Direct, and EBSCO to find citations from the beginning of January 2019 until the beginning of April 2020 without any restrictions.

Results: Finally, 51 studies, including 5,490 COVID-19 patients, were included in the present metaanalysis. The prevalence of different factors observed in laboratory findings was as follows: the prevalence of lymphopenia in patients with COVID-19 accounted for 51.6% (95% CI: 44.0-59.1), elevated C-reactive protein (CRP) was 63.6% (95% CI: 57.0-69.8), elevated erythrocyte sedimentation rate (ESR) was 62.5% (95% CI: 50.1-73.5), elevated tumor necrosis factor alpha (TNFα) was 28.7% (95% CI: 9.0-62.1), elevated serum amyloid-A level was 74.7% (95% CI: 50.0-89.7), elevated procalcitonin level was 72.6% (95% CI: 58.1-83.5), elevated interleukin-6 level was 59.9% (95% CI: 48.2-70.5), reduced CD3 level was 68.3% (95% CI: 50.1-82.2), reduced CD4 level was 62.0% (95% CI: 51.1- 71.6), elevated lactate dehydrogenase (LDH) level accounted for 53.1% (95% CI: 43.6-62.4), elevated brain natriuretic peptide (BNP) accounted for 48.9% (95% CI: 30.4-67.7), reduced albumin and reduced pre-albumin levels in patients with COVID-19 were estimated to be 54.7% (95% CI: 38.1-70.2) and 49.0% (95% CI: 26.6-71.8), and D-dimer level was 44.9% (95% CI: 31.0-59.6).

Conclusion: The results show lymphopenia, elevated ESR level, elevated CRP level, elevated serum amyloid-A, elevated TNFα, elevated procalcitonin level, elevated interleukin-6 level, reduced CD3, reduced CD4, elevated BNP, elevated LDH, reduced albumin, reduced pre-albumin, and elevated Ddimer levels as the most common findings at the time of admission.

Graphical Abstract

[1]
Karimian M, Azami M. Chest computed tomography scan findings of coronavirus disease 2019 (COVID-19) patients: a comprehensive systematic review and meta-analysis. Pol J Radiol 2021; 86(1): 31-49.
[http://dx.doi.org/10.5114/pjr.2021.103379]
[2]
Azami M, Nasirkandy MP, Esmaeili Gouvarchin Ghaleh H, Ranjbar R. COVID-19 vaccine acceptance among pregnant women worldwide: A systematic review and meta-analysis. PLoS One 2022; 17(9): e0272273.
[PMCID: PMC9518917]
[3]
Saeidi E, Ranjbar R, Zangoei-Fard S, Guest PC, Sahebkar A. Virology, epidemiology and control of SARS-CoV-2: A perspective. Nanomedicine Research Journal 2021; 6(2): 96-104.
[4]
Zhou S, Wang Y, Zhu T, Xia L. CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China. AJR Am J Roentgenol 2020; 214(6): 1287-94.
[PMID: 32134681]
[5]
Cao J, Tu WJ, Cheng W, et al. Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis 2020; 71(15): 748-55.
[PMID: 7184479]
[6]
Cui P, Chen Z, Wang T, et al. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract. Am J Obstet Gynecol 2020; 223(1): 131-4.
[PMID: 32376320]
[7]
Jia N, Feng D, Fang LQ, et al. Case fatality of SARS in mainland China and associated risk factors Trop Med Int Health 2009; 14(Suppl 1)(Suppl. 1): 21-7.
[http://dx.doi.org/10.1111/j.1365-3156.2008.02147.x] [PMID: 19508439]
[8]
Hosseini MJ, Halaji M, Nejad JH, Ranjbar R. Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran. J Neurovirol 2021; 27(3): 507-9.
[http://dx.doi.org/10.1007/s13365-021-00979-9] [PMID: 33876411]
[9]
Lashkari A, Ranjbar R. A case-based systematic review on the SARS-COVID-2-associated cerebrovascular diseases and the possible virus routes of entry. J Neurovirol 2021; 27(5): 691-701.
[http://dx.doi.org/10.1007/s13365-021-01013-8] [PMID: 34546547]
[10]
Zhao Z, Chen A, Hou W, et al. Prediction model and risk scores of ICU admission and mortality in COVID-19. PLoS One 2020; 15(7): e0236618.
[http://dx.doi.org/10.1371/journal.pone.0236618] [PMID: 32730358]
[11]
Ahmadzadeh-Darinsoo M, Akbariqomi M, Ahmadzadeh-Darinsoo M, Ranjbar R, Arabfard M, Razei A, et al. Clinical features of covid-19 hospitalized patients with and without chronic kidney disease: A single-center, cross-sectional study. Electron J Gen Med 2022; 19(2): em345.
[12]
Halaji M, Heiat M, Faraji N, Ranjbar R. Epidemiology of COVID-19: An updated review. J Res Med Sci 2021; 26: 82.
[13]
Nejad JH, Allahyari F, Hosseinzadeh R, Heiat M, Ranjbar R. Neurological symptoms of COVID-19 infection; a cross-sectional study on hospitalized COVID-19 patients in Iran. Clin Neurol Neurosurg 2021; 210: 106985.
[http://dx.doi.org/10.1016/j.clineuro.2021.106985] [PMID: 34700274]
[14]
Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Infez Med 2020; 28 (Suppl. 1): 6-17.
[PMID: 32532933]
[15]
Ranjbar R, Mahmoodzadeh Hosseini H, Safarpoor Dehkordi F. A review on biochemical and immunological biomarkers used for laboratory diagnosis of SARS-CoV-2 (COVID-19). Open Microbiol J 2020; 14(1): 290-6.
[http://dx.doi.org/10.2174/1874434602014010290]
[16]
Mirzaei R, Karampoor S, Sholeh M, Moradi P, Ranjbar R, Ghasemi F. A contemporary review on pathogenesis and immunity of COVID-19 infection. Mol Biol Rep 2020; 47(7): 5365-76.
[http://dx.doi.org/10.1007/s11033-020-05621-1] [PMID: 32601923]
[17]
Allahyari F, Hosseinzadeh R, Nejad JH, Heiat M, Ranjbar R. A case report of simultaneous autoimmune and COVID-19 encephalitis. J Neurovirol 2021; 27(3): 504-6.
[http://dx.doi.org/10.1007/s13365-021-00978-w] [PMID: 33904138]
[18]
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507-13.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[19]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[20]
Aghamollaei H, Sarvestani R, Bakherad H, Zare H, Guest PC, Ranjbar R, et al. Emerging technologies for the treatment of covid-19.clinical, biological and molecular aspects of COVID-19. Adv Exp Med Biol 2021; 1321: 81-96.
[http://dx.doi.org/10.1007/978-3-030-59261-5_7]
[21]
Mohammadpour S, Torshizi Esfahani A, Halaji M, Lak M, Ranjbar R. An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19. J Cell Physiol 2021; 236(1): 49-54.
[PMID: 32542735]
[22]
Cao M, Zhang D, Wang Y, Lu Y, Zhu X, Li Y, et al. Clinical features of patients infected with the 2019 novel coronavirus (COVID-19) in Shanghai, China. MedRxiv 2020.
[http://dx.doi.org/10.1101/2020.03.04.20030395]
[23]
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunologic features in severe and moderate forms of Coronavirus Disease. J Clin Invest 2020; 130(5): 2620-9.
[24]
Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020; 20(4): 425-34.
[http://dx.doi.org/10.1016/S1473-3099(20)30086-4] [PMID: 32105637]
[25]
Huang Y, Tu M, Wang S, et al. Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis. Travel Med Infect Dis 2020; 36: 101606.
[http://dx.doi.org/10.1016/j.tmaid.2020.101606] [PMID: 32114074]
[26]
Xu X-W, Wu X-X, Jiang X-G, Xu K-J, Ying L-J, Ma C-L, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020; 368: m606.
[PMID: 32075786]
[27]
Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. J Infect 2020; 80(4): 388-93.
[http://dx.doi.org/10.1016/j.jinf.2020.02.016] [PMID: 32112884]
[28]
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med 2020; 382: 1708.
[http://dx.doi.org/10.1056/NEJMoa2002032]
[29]
Chen X, Zheng F, Qing Y, Ding S, Yang D, Lei C. Epidemiological and clinical 250 features of 291 cases with coronavirus disease. areas adjacent to Hubei China. medRxiv 2019; 251.
[30]
Xu X, Yu C, Qu J, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging 2020; 47(5): 1275-80.
[http://dx.doi.org/10.1007/s00259-020-04735-9] [PMID: 32107577]
[31]
Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J. Clinical Characteristics of 25 Death Cases Infected with COVID-19 Pneumonia: A retrospective Review of Medical Records in a Single Medical Center, Wuhan, China. medRxiv 2020.
[32]
Jian-ya G. Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing, China. MedRxiv 2020. [Google Scholar].
[http://dx.doi.org/10.1101/2020.02.20.20025536]
[33]
Liang Y, Liang J, Zhou Q, et al. Prevalence and clinical features of 2019 novel coronavirus disease (COVID-19) in the fever clinic of a teaching hospital in Beijing: a single-center, retrospective study. medRxiv 2020. 02 https://www.medrxiv.org/content/10.1101/2020.02.25.20027763v2
[34]
Li J, Zhang Y, Wang F, et al. Sex differences in clinical findings among patients with coronavirus disease 2019 (COVID-19) and severe condition. medRxiv 2020.
[http://dx.doi.org/10.1101/2020.02.27.20027524]
[35]
Huang Y, Yang R, Xu Y, Gong P. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv 2020.
[http://dx.doi.org/10.1101/2020.02.27.20029009]
[36]
Yang P, Ding Y, Xu Z, et al. Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China. Medrxiv 2020.
[http://dx.doi.org/10.1101/2020.02.28.20028068]
[37]
Fu H, Li H, Tang X, et al. Analysis on the clinical characteristics of 36 cases of novel coronavirus pneumonia in Kunming. medRxiv 2020.
[http://dx.doi.org/10.1101/2020.02.28.20029173]
[38]
Liu T, Zhang J, Yang Y, et al. The role of interleukin-6 in monitoring severe case of coronavirus disease 2019. EMBO Mol Med 2020; 12(7): e12421.
[http://dx.doi.org/10.15252/emmm.202012421] [PMID: 32428990]
[39]
Zhang G, Hu C, Luo L, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol 2020; 127: 104364.
[http://dx.doi.org/10.1016/j.jcv.2020.104364] [PMID: 32311650]
[40]
Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol 2020; 55(5): 1169-74.
[http://dx.doi.org/10.1002/ppul.24718] [PMID: 32134205]
[41]
Wu J, Wu X, Zeng W, et al. Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features. Invest Radiol 2020; 55(5): 257-61.
[http://dx.doi.org/10.1097/RLI.0000000000000670] [PMID: 32091414]
[42]
Wu J, Liu J, Zhao X, et al. Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multi-center descriptive study. Clin Infect Dis 2020; 71(15): 706-12.
[http://dx.doi.org/10.1093/cid/ciaa199] [PMID: 32109279]
[43]
Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin Med J (Engl) 2020; 133(9): 1025-31.
[http://dx.doi.org/10.1097/CM9.0000000000000744] [PMID: 32044814]
[44]
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395(10229): 1054-62.
[http://dx.doi.org/10.1016/S0140-6736(20)30566-3] [PMID: 32171076]
[45]
Zhang F, He L, Ouyang Y, Gong J, Li X, Wei Y, et al. Clinical features of 81 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Jingzhou, China: A descriptive study. SSRN 2020.
[46]
Jiehao C, Jin X, Daojiong L, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis 2020; 71(6): 1547-51.
[http://dx.doi.org/10.1093/cid/ciaa198] [PMID: 32112072]
[47]
Xu YH, Dong JH, An WM, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect 2020; 80(4): 394-400.
[http://dx.doi.org/10.1016/j.jinf.2020.02.017] [PMID: 32109443]
[48]
Liu H, Gao J, Wang Y, et al. Epidemiological and clinical characteristics of 2019 novel coronavirus disease (COVID-19) in Jilin, China: A descriptive study. Medicine (Baltimore) 2020; 99(47): e23407.
[http://dx.doi.org/10.1097/MD.0000000000023407] [PMID: 33217886]
[49]
Wei Y, Lu Y, Xia L, et al. Analysis of 2019 novel coronavirus infection and clinical characteristics of outpatients: An epidemiological study from a fever clinic in Wuhan, China. J Med Virol 2020; 92(11): 2758-67.
[http://dx.doi.org/10.1002/jmv.26175] [PMID: 32544281]
[50]
Xiong Y, Sun D, Liu Y, et al. Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes. Invest Radiol 2020; 55(6): 332-9.
[http://dx.doi.org/10.1097/RLI.0000000000000674] [PMID: 32134800]
[51]
Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020; 63(3): 364-74.
[http://dx.doi.org/10.1007/s11427-020-1643-8] [PMID: 32048163]
[52]
Lu C, Yang W, Hu Y, Hui J, Zhou G, Shu J, et al. Coronavirus disease 2019 (COVID-19) pneumonia: Early stage chest CT imaging features and clinical relevance. SSRN 2020; 25.
[53]
Liu P, Niu R, Chen J, et al. Epidemiological and clinical features in patients with coronavirus disease 2019 outside of Wuhan, China: Special focus in asymptomatic patients. PLoS Negl Trop Dis 2021; 15(3): e0009248.
[http://dx.doi.org/10.1371/journal.pntd.0009248] [PMID: 33690662]
[54]
Liu H, Liu F, Li J, Zhang T, Wang D, Lan W. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children. J Infect 2020; 80(5): e7-e13.
[http://dx.doi.org/10.1016/j.jinf.2020.03.007] [PMID: 32171865]
[55]
Chen L, Liu H, Liu W, Liu J, Liu K, Shang J, et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Chin J Tubercul Respir Dis 2020; 43: E005.
[56]
Zhu X, Yuan W, Huang K, Wang Q, Yao S, Lu W, et al. Clinical features and short-term outcomes of 114 elderly patients with COVID-19 in Wuhan, China: A single-center, retrospective, observational study. Lancet 2020. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3548774
[57]
Li K, Wu J, Wu F, et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest Radiol 2020; 55(6): 327-31.
[http://dx.doi.org/10.1097/RLI.0000000000000672] [PMID: 32118615]
[58]
Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv 2020.
[http://dx.doi.org/10.1101/2020.02.10.20021832]
[59]
Liu L, Gao J-Y, Hu W-m, Zhang X-x, Guo L, Liu C-q, et al. Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing, China. MedRxiv 2020.
[http://dx.doi.org/10.1101/2020.02.20.20025536]
[60]
Zhang B, Zhou X, Qiu Y, et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS One 2020; 15(7): e0235458.
[http://dx.doi.org/10.1371/journal.pone.0235458] [PMID: 32645044]
[61]
Qi D, Yan X, Tang X, et al. Epidemiological and clinical features of 2019-NCoV acute respiratory disease cases in Chongqing Municipality, China: A retrospective, descriptive, multiple-center study. medRxiv 2020. [preprint].
[http://dx.doi.org/10.1101/2020.03.01.20029397]
[62]
Xu Y, Xu Z, Liu X, et al. Clinical findings of COVID-19 patients admitted to intensive care units in Guangdong Province, China: a multi-center, retrospective, observational study. Front Med (Lausanne) 2020; 7: 576457.
[http://dx.doi.org/10.3389/fmed.2020.576457] [PMID: 33195325]
[63]
Liao J, Fan S, Chen J, et al. Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults. Innovation 2020; 1(1): 100001.
[PMID: 33554183]
[64]
Lei Y, Huang X, Lang B, Lan Y, Lu J, et al. Clinical features of imported cases of coronavirus disease 2019 in Tibetan patients in the Plateau area. MedRxiv 2020.
[http://dx.doi.org/10.1101/2020.03.09.20033126]
[65]
Zhang C, Gu J, Chen Q, Deng N, Li J, Huang L, et al. Clinical characteristics of 34 children with coronavirus disease-2019 in the west of China: a multiple-center case series. MedRxiv 2020.
[http://dx.doi.org/10.1101/2020.03.12.20034686]
[66]
Liu J, Ouyang L, Fu P, Cao Y, Yang D, Han X, et al. Epidemiological, clinical, radiological characteristics and outcomes of medical staff with COVID-19 in Wuhan, China: A single-centered, retrospective case series analysis. Int J Med Sci 2020; 18(6): 1492-501.
[67]
Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75(7): 1730-41.
[http://dx.doi.org/10.1111/all.14238] [PMID: 32077115]
[68]
Pan Y, Ye G, Zeng X, et al. Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of community-acquired pneumonia? Clin Transl Med 2020; 10(1): 161-8.
[http://dx.doi.org/10.1002/ctm2.23] [PMID: 32508038]
[69]
Sayehmiri K, Tavan H, Sayehmiri F, Mohammadi IV, Carson K. Prevalence of epilepsy in iran: a meta-analysis and systematic review. Iran J Child Neurol 2014; 8(4): 9-17.
[PMID: 25657765]
[70]
Sayehmiri K, Tavan H. Systematic review and meta-analysis methods prevalence of peptic ulcer in IRAN. J Govaresh 2015; 20(4): 250-8.
[71]
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4(1): 1-9.
[http://dx.doi.org/10.1186/2046-4053-4-1] [PMID: 25554246]
[72]
Luchini C, Stubbs B, Solmi M, Veronese N. Assessing the quality of studies in meta-analyses: Advantages and limitations of the Newcastle Ottawa Scale. World J Metaanal 2017; 5(4): 80-4.
[http://dx.doi.org/10.13105/wjma.v5.i4.80]
[73]
Tarsilla M. Cochrane handbook for systematic reviews of interventions. J Multidiscip Eval 2010; 6(14): 142-8.
[74]
Ades AE, Lu G, Higgins JPT. The interpretation of random-effects meta-analysis in decision models. Med Decis Making 2005; 25(6): 646-54.
[http://dx.doi.org/10.1177/0272989X05282643] [PMID: 16282215]
[75]
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50(4): 1088-101.
[http://dx.doi.org/10.2307/2533446] [PMID: 7786990]
[76]
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020; 34: 101623.
[http://dx.doi.org/10.1016/j.tmaid.2020.101623] [PMID: 32179124]
[77]
Cao Y, Liu X, Xiong L, Cai K. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis. J Med Virol 2020; 92(9): 1449-59.
[http://dx.doi.org/10.1002/jmv.25822] [PMID: 32242947]
[78]
Hahn WH, Song JH, Kim H, Park S. Is procalcitonin to C-reactive protein ratio useful for the detection of late onset neonatal sepsis? J Matern Fetal Neonatal Med 2018; 31(6): 822-6.
[http://dx.doi.org/10.1080/14767058.2017.1297410] [PMID: 28277917]
[79]
Tan C, Huang Y, Shi F, et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol 2020; 92(7): 856-62.
[http://dx.doi.org/10.1002/jmv.25871] [PMID: 32281668]
[80]
Ng CT, Snell LM, Brooks DG, Oldstone MBA. Networking at the level of host immunity: immune cell interactions during persistent viral infections. Cell Host Microbe 2013; 13(6): 652-64.
[http://dx.doi.org/10.1016/j.chom.2013.05.014] [PMID: 23768490]
[81]
Saeed K, Dale AP, Leung E, et al. Procalcitonin levels predict infectious complications and response to treatment in patients undergoing cytoreductive surgery for peritoneal malignancy. Eur J Surg Oncol 2016; 42(2): 234-43.
[http://dx.doi.org/10.1016/j.ejso.2015.10.004] [PMID: 26560024]
[82]
Fenwick C, Joo V, Jacquier P, et al. T-cell exhaustion in HIV infection. Immunol Rev 2019; 292(1): 149-63.
[http://dx.doi.org/10.1111/imr.12823] [PMID: 31883174]
[83]
Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 2020; 11: 827.
[http://dx.doi.org/10.3389/fimmu.2020.00827] [PMID: 32425950]
[84]
Bonig H, Papayannopoulou T. Mobilization of hematopoietic stem/progenitor cells: general principles and molecular mechanisms. Methods Mol Biol 2012; 904: 1-14.
[85]
Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111(12): 1805-12.
[http://dx.doi.org/10.1172/JCI200318921] [PMID: 12813013]
[86]
Choi JJ, McCarthy MW. Novel applications for serum procalcitonin testing in clinical practice. Expert Rev Mol Diagn 2018; 18(1): 27-34.
[http://dx.doi.org/10.1080/14737159.2018.1407244] [PMID: 29148856]
[87]
Zhang L, Zhang X. Serum sTREM-1, PCT, CRP, Lac as biomarkers for death risk within 28 days in patients with severe sepsis. Open Life Sci 2018; 13(1): 42-7.
[http://dx.doi.org/10.1515/biol-2018-0006] [PMID: 33817066]
[88]
Rodríguez A, Reyes LF, Monclou J, et al. Relationship between acute kidney injury and serum procalcitonin (PCT) concentration in critically ill patients with influenza infection. Med Intensiva 2018; 42(7): 399-408.
[http://dx.doi.org/10.1016/j.medin.2017.12.004] [PMID: 29433841]
[89]
Bosch BJ, van der Zee R, de Haan CAM, Rottier PJM. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003; 77(16): 8801-11.
[http://dx.doi.org/10.1128/JVI.77.16.8801-8811.2003] [PMID: 12885899]
[90]
Huang KJ, Su IJ, Theron M, et al. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 2005; 75(2): 185-94.
[http://dx.doi.org/10.1002/jmv.20255] [PMID: 15602737]
[91]
Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis 2020; 63(3): 390-1.
[http://dx.doi.org/10.1016/j.pcad.2020.03.001] [PMID: 32169400]
[92]
Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426(6965): 450-4.
[http://dx.doi.org/10.1038/nature02145] [PMID: 14647384]
[93]
Nejad JH, Heiat M, Hosseini MJ, et al. Guillain-Barré syndrome associated with COVID-19: a case report study. J Neurovirol 2021; 27(5): 802-5.
[http://dx.doi.org/10.1007/s13365-021-00984-y] [PMID: 34046865]
[94]
Rapala-Kozik M, Karkowska J, Jacher A, et al. Kininogen adsorption to the cell surface of Candida spp. Int Immunopharmacol 2008; 8(2): 237-41.
[http://dx.doi.org/10.1016/j.intimp.2007.07.005] [PMID: 18182233]
[95]
Loof TG, Mörgelin M, Johansson L, et al. Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood 2011; 118(9): 2589-98.
[http://dx.doi.org/10.1182/blood-2011-02-337568] [PMID: 21613262]
[96]
Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020; 58(7): 1116-20. [CCLM].
[http://dx.doi.org/10.1515/cclm-2020-0188] [PMID: 32172226]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy